No tax




Security policy (edit with Customer reassurance module)


Delivery policy (edit with Customer reassurance module)


Return policy (edit with Customer reassurance module)


Allomedin - a dermatological agent designed to protect the skin and mucous membranes from viruses that cause inflammation and epithelial neoplasms

Allomedin - a dermatological agent designed to protect the skin and mucous membranes from viruses that cause inflammation and neoplasm of epithelial tissues. The main active component of Allomedin is a synthetic peptide, alloferon-3.

Alloferony is a new group of drugs of natural origin, isolated from the immune system of surgical larvae. Alloferon-3 retains all the basic properties of natural alloferon and at the same time has a number of advantages that make its use particularly promising in dermatology and cosmetology. Penetrating into the epithelium tissue, alloferon-3 activates immunocompetent cells to recognize pathologically changed skin cells and starts a cascade of defensive reactions aimed at suppressing the replication and spread of herpes viruses, papillomas, etc. At the same time, the drug does not have a damaging effect on surrounding normal cells. Eliminating the source of infection and stimulating the subsequent regeneration of the epithelium, alloferon-3 provides a quick recovery of the normal state of the skin.


Allomedin is available as a clear, colorless, odorless hydrogel.It contains alloferon-3 peptide and auxiliary ingredients that are widely used as components of dermatological and cosmetic products: allantoin, glycerin, urea, carbopol, kemaben, triethanolamine.


Allomedin is designed to restore healthy areas of the skin and mucous membranes infected with herpes viruses, papillomas, and other viruses that can damage epithelial tissue. The efficacy of Allomedin for skin infections caused by the herpes simplex virus (labial herpes, genital herpes, herpetic stomatitis), and also papillomas of various localization (common warts, genital warts, papillomas of the larynx and respiratory tract, and cervical intraepithelial dysplasia is established clinically.



The use of Allomedin when the first symptoms of herpes appear gives the best result. In this case, unpleasant subjective sensations (burning, itching) disappear within a few hours, and the development of herpetic eruptions usually stops. If the period of the first symptoms of exacerbation is missed, it may take 3-6 days to fully recover. The experience of clinical use of alloferon shows that the frequent result of the treatment of recurrent herpes is a significant, up to six months or more, an increase in disease-free period
In papillomatosis, the use of Allomedin leads to the elimination of inflammation, the suppression of the reproduction of the virus and its spread beyond the site of infection.A particularly important result of the use of Allomedin is to prevent the formation of new papillomas and reduce the risk of cancer caused by oncogenic types of human papillomavirus.

Dosing regimen

Allomedin is applied to damaged areas of the skin and mucous membranes, where it is rapidly absorbed and has a local protective and regenerating effect. The duration of the course depends on the nature of the damage.

With minor herpetic eruptions in the face, it is usually enough to apply the gel 1-3 times during the day for 1-2 days.
For more severe herpes virus lesions, the gel should be applied 1-2 times a day for 5-7 days.
When treating dysplasias, neoplasias, subclinical manifestations of HPV infections, genital warts, before their destruction it is recommended to conduct a course of gel applications (1-2 times a day for 5-7 days).
When treating neoplasms caused by oncogenic types of papillomavirus, it is advisable to use Allokin-alpha in parallel (1 mg subcutaneously after one day; three injections per course). This scheme allows you to remove the virus from the neoplasm, reduce the area of ​​the surgical field and minimize the risk of tumor degeneration of neoplasms caused by HPV.

Side effect

Allomedin meets the highest standards of safety of dermato-cosmetological means. To date, any undesirable side effects of Allomedin have not been described.This does not exclude the possibility of individual intolerance to the components of the gel by individuals. In such cases, its use is contraindicated.
In some people, the use of Allomedin can cause the appearance of additional herpetic eruptions. This effect is associated with increased immunological recognition of latent viral infection foci and the subsequent development of an inflammatory response. Such a reaction can be perceived as a worsening of the patient’s condition, however, it contributes to the elimination of the foci of reproduction of the virus and the attainment of this persistent healing effect. At the same time, the existence of a latent viral infection identified by Allomedin indicates a possible defect in the antiviral immunity system. On this occasion, you should consult with a specialist physician (preferably an immunologist).
Prior consultation with experts also requires the use of Allomedin in children under 12 years of age, pregnant women with allergic skin diseases. Such treatment should be carried out by a specialist doctor.

Drug interaction

Clinical data suggest the feasibility of combining Allomedin with Allokin-alpha treatment (alloferon-1 injection form). The combination of local (Allomedin) and systemic (Allokin-alpha) use of two types of alloferons provides the maximum therapeutic effect.

Terms and conditions of storage

The gel in the intact original packaging can be stored for 1 year from the date of manufacture at a temperature of + 2-8 degrees. C (normal mode of domestic refrigerator). Acceptable storage of the gel at room temperature for 1-2 months.

42 Items